ResMed Announces Participation in the 24th Annual Macquarie Australia ConferenceGlobeNewsWire • 04/27/22
Chronic Disease Management Startup Curie AI Secures Seed Funding From ResMed to Advance Respiratory Illness Evaluation and CareBusiness Wire • 04/12/22
ResMed Announces Participation in the KeyBanc Capital Markets' Life Sciences & MedTech Investor ForumGlobeNewsWire • 03/17/22
ResMed's Global Sleep Surveys Reveal What's Keeping Us Up at Night; Aim to Bring Awareness to the State of Sleep Health for World Sleep DayGlobeNewsWire • 03/14/22
ResMed Announces Participation in the Oppenheimer 32nd Annual Healthcare ConferenceGlobeNewsWire • 03/10/22
ResMed Q2 Earnings Highlights: Supply Chain Constraints, Unlimited Demand Due To Competitor RecallBenzinga • 01/28/22
ResMed Inc. (RMD) CEO Mick Farrell on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 01/28/22
Down 9.2% in 4 Weeks, Here's Why You Should You Buy the Dip in ResMed (RMD)Zacks Investment Research • 01/10/22
ResMed Announces Participation in the 40th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/03/22